Oxidative stress and nucleic acid oxidation in patients with chronic kidney disease

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Sung, Chih Chien ^a,b   Hsu, Yu Chuan ^c   Chen, Chun Chi ^a   Lin, Yuh Feng ^d,e   Wu, Chia Chao ^a,b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c TAO YUAN GENERAL HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN-CONVERTING ENZYME; ANTIOXIDANT DEFENCE; ANTIOXIDANT DEFENSE; ANTIOXIDANT THERAPIES; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE; CLINICAL BIOMARKERS; HYPERHOMOCYSTEINEMIA;

AMINO ACIDS; ANTIOXIDANTS; BIOMOLECULES; DIALYSIS; DIALYSIS MEMBRANES; DISEASES; OXIDATIVE STRESS;

NUCLEIC ACIDS;

ALPHA TOCOPHEROL; ARACHIDONIC ACID DERIVATIVE; AROMATIC AMINO ACID; ASCORBIC ACID; BARDOXOLONE METHYL; BIOLOGICAL MARKER; CARBOHYDRATE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUTATHIONE TRANSFERASE; INDICAN; MITOCHONDRIAL DNA; NITROGEN DERIVATIVE; NUCLEIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; UREMIC TOXIN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REACTIVE NITROGEN SPECIES;

AMYLOIDOSIS; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; CHRONIC KIDNEY DISEASE; COMET ASSAY; DNA DAMAGE; DNA POLYMORPHISM; HUMAN; HYPERHOMOCYSTEINEMIA; LIPID PEROXIDATION; MICRONUCLEUS; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN CARBONYLATION; REVIEW; CHRONIC KIDNEY FAILURE; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

HUMANS; KIDNEY FAILURE, CHRONIC; NADP; NUCLEIC ACIDS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES;

EID: 84884245354     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/301982     Document Type: Review

References (149)

1. Maisonneuve P., Agodoa L., Gellert R., Stewart J. H., Buccianti G., Lowenfels A. B., Wolfe R. A., Jones E., Disney A. P. S., Briggs D., McCredie M., Boyle P., Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. The Lancet 1999 354 9173 93 99 2-s2.0-0033542845 10.1016/S0140-6736(99)06154-1
2. Teschner M., Garte C., Rückle-Lanz H., Mäder U., Stopper H., Klassen A., Heidland A., Incidence and spectrum of malignant disease among dialysis patients in North Bavaria. Deutsche Medizinische Wochenschrift 2002 127 47 2497 2502 2-s2.0-0037159835 10.1055/s-2002-35637
3. Vaziri N. D., Oveisi F., Ding Y., Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney International 1998 53 6 1748 1754 2-s2.0-0031749824 10.1046/j.1523-1755.1998.00947.x
4. Tepel M., Echelmeyer M., Orie N. N., Zidek W., Increased intracellular reactive oxygen species in patients with end-stage renal failure: effect of hemodialysis. Kidney International 2000 58 2 867 872 2-s2.0-0033854483 10.1046/j.1523-1755.2000.00236.x
5. Galle J., Oxidative stress in chronic renal failure. Nephrology Dialysis Transplantation 2001 16 11 2135 2137 2-s2.0-0035172345
6. Palleschi S., de Angelis S., Diana L., Rossi B., Papa V., Severini G., Splendiani G., Reliability of oxidative stress biomarkers in hemodialysis patients: a comparative study. Clinical Chemistry and Laboratory Medicine 2007 45 9 1211 1218 2-s2.0-34548563969 10.1515/CCLM.2007.266
7. Halliwell B., Gutteridge J. M. C., Free Radicals in Biology and Medicine 1999 3rd Oxford, UK Oxford University Press
8. Errakonda P. R., Paladugu R., Bitla A. R., Musturu S. M., Lakshman J., Pemmaraju S. R. V. L. N., Vishnubhotla S., Effect of a single hemodialysis session on endothelial dysfunction. Journal of Nephrology 2011 24 1 83 90 2-s2.0-78651255043 10.5301/JN.2010.4926
9. Dursun B., Dursun E., Suleymanlar G., Ozben B., Capraz I., Apaydin A., Ozben T., Carotid artery intima-media thickness correlates with oxidative stress in chronic haemodialysis patients with accelerated atherosclerosis. Nephrology Dialysis Transplantation 2008 23 5 1697 1703 2-s2.0-44449117371 10.1093/ndt/gfm906
10. Diplock A. T., Charleux J.-L., Crozier-Willi G., Kok F. J., Rice-Evans C., Roberfroid M., Stahl W., Viña-Ribes J., Functional food science and defence against reactive oxidative. British Journal of Nutrition 1998 80 supplement 1 S77 S112 2-s2.0-0031656737
11. Ames B. N., Endogenous oxidative DNA damage, aging and cancer. Free Radical Research Communications 1989 7 3-6 121 128 2-s2.0-0024460992
12. Schulz W. A., Obendorf M. S. W., Sies H., Localization of strand breaks in plasmid DNA treated with reactive oxygen species. Methods in Enzymology 1994 234 45 51 2-s2.0-0027988860 10.1016/0076-6879(94)34075-7
13. Beckman K. B., Ames B. N., Oxidative decay of DNA. Journal of Biological Chemistry 1997 272 32 19633 19636 2-s2.0-0030839865 10.1074/jbc.272.32.19633
14. Descamps-Latscha B., Drüeke T., Witko-Sarsat V., Dialysis-induced oxidative stress: biological aspects, clinical consequences, and therapy. Seminars in Dialysis 2001 14 3 193 199 2-s2.0-0035350459
15. Bedard K., Krause K.-H., The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological Reviews 2007 87 1 245 313 2-s2.0-33846794822 10.1152/physrev.00044.2005
16. Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A., Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proceedings of the National Academy of Sciences of the United States of America 1990 87 4 1620 1624 2-s2.0-0025189864
17. Davies K. J., Protein damage and degradation by oxygen radicals. I. general aspects. Journal of Biological Chemistry 1987 262 20 9895 9901 2-s2.0-0023655369
18. Wolff S. P., Garner A., Dean R. T., Free radicals, lipids and protein degradation. Trends in Biochemical Sciences 1986 11 1 27 31 2-s2.0-0022644072
19. Imlay J. A., Linn S., DNA damage and oxygen radical toxicity. Science 1988 240 4857 1302 1309 2-s2.0-0023886170
20. Locatelli F., Canaud B., Eckardt K.-U., Stenvinkel P., Wanner C., Zoccali C., Oxidative stress in end-stage renal disease: an emerging treat to patient outcome. Nephrology Dialysis Transplantation 2003 18 7 1272 1280 2-s2.0-0038353176
21. Wang Z., Nicholls S. J., Rodriguez E. R., Kummu O., Hörkkö S., Barnard J., Reynolds W. F., Topol E. J., DiDonato J. A., Hazen S. L., Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nature Medicine 2007 13 10 1176 1184 2-s2.0-34948834705 10.1038/nm1637
22. Kalantar-Zadeh K., Brennan M.-L., Hazen S. L., Serum myeloperoxidase and mortality in maintenance hemodialysis patients. The American Journal of Kidney Diseases 2006 48 1 59 68 2-s2.0-33745197790 10.1053/j.ajkd.2006.03.047
23. Cristol J. P., Canaud B., Rabesandratana H., Gaillard I., Serre A., Mion C., Enhancement of reactive oxygen species production and cell surface markers expression due to haemodialysis. Nephrology Dialysis Transplantation 1994 9 4 389 394 2-s2.0-0028316230
24. Chen M.-F., Chang C.-L., Liou S.-Y., Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis. Blood Purification 1998 16 5 290 300 2-s2.0-0032430704 10.1159/000014347
25. Ghezzi P., Bonetto V., Fratelli M., Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation. Antioxidants and Redox Signaling 2005 7 7-8 964 972 2-s2.0-22044445670 10.1089/ars.2005.7.964
26. Himmelfarb J., Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy. Seminars in Dialysis 2009 22 6 636 643 2-s2.0-71549120440 10.1111/j.1525-139X.2009.00659.x
27. Himmelfarb J., Stenvinkel P., Ikizler T. A., Hakim R. M., Perspectives in renal medicine: the elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney International 2002 62 5 1524 1538 2-s2.0-0036833743 10.1046/j.1523-1755.2002.00600.x
28. Scholze A., Rinder C., Beige J., Riezler R., Zidek W., Tepel M., Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure. Circulation 2004 109 3 369 374 2-s2.0-1642458129 10.1161/01.CIR.0000109492. 65802.AD
29. Gongora M. C., Lob H. E., Landmesser U., Guzik T. J., Martin W. D., Ozumi K., Wall S. M., Wilson D. S., Murthy N., Gravanis M., Fukai T., Harrison D. G., Loss of extracellular superoxide dismutase leads to acute lung damage in the presence of ambient air: a potential mechanism underlying adult respiratory distress syndrome. The American Journal of Pathology 2008 173 4 915 926 2-s2.0-53149108208 10.2353/ajpath.2008.080119
30. Kobayashi M., Sugiyama H., Wang D.-H., Toda N., Maeshima Y., Yamasaki Y., Masuoka N., Yamada M., Kira S., Makino H., Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice. Kidney International 2005 68 3 1018 1031 2-s2.0-32644478793 10.1111/j.1523-1755. 2005.00494.x
31. Ursini F., Maiorino M., Gregolin C., The selenoenzyme phospholipid hydroperoxide glutathione peroxidase. Biochimica et Biophysica Acta 1985 839 1 62 70 2-s2.0-0021803196 10.1016/0304-4165(85)90182-5
32. Avissar N., Ornt D. B., Yagil Y., Horowitz S., Watkins R. H., Kerl E. A., Takahashi K., Palmer I. S., Cohen H. J., Human kidney proximal tubules are the main source of plasma glutathione peroxidase. The American Journal of Physiology 1994 266 2 C367 C375 2-s2.0-0028005750
33. Wood Z. A., Schröder E., Harris J. R., Poole L. B., Structure, mechanism and regulation of peroxiredoxins. Trends in Biochemical Sciences 2003 28 1 32 40 2-s2.0-0037222255 10.1016/S0968-0004(02)00003-8
34. Canaud B., Cristol J.-P., Morena M., Leray-Moragues H., Bosc J.-Y., Vaussenat F., Imbalance of oxidants and antioxidants in haemodialysis patients. Blood Purification 1999 17 2-3 99 106 2-s2.0-0032800789 10.1159/000014381
35. Ceballos-Picot I., Witko-Sarsat V., Merad-Boudia M., Nguyen A. T., Thévenin M., Jaudon M. C., Zingraff J., Verger C., Jungers P., Descamps-Latscha B., Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radical Biology and Medicine 1996 21 6 845 853 2-s2.0-0037839029 10.1016/0891-5849(96)00233-X
36. Bonomini M., Albertazzi A., Selenium in uremia. Artificial Organs 1995 19 5 443 448 2-s2.0-0029039199
37. Tarng D.-C., Tsai T.-J., Chen W.-T., Liu T.-Y., Wei Y.-H., Effect of human OGG1 1245C→G gene polymorphism on 8-hydroxy-2′-deoxyguanosine levels of leukocyte DNA among patients undergoing chronic hemodialysis. Journal of the American Society of Nephrology 2001 12 11 2338 2347 2-s2.0-0034752606
38. Kohno T., Shinmura K., Tosaka M., Tani M., Kim S.-R., Sugimura H., Nohmi T., Kasai H., Yokota J., Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998 16 25 3219 3225 2-s2.0-0032565998
39. Trabulus S., Guven G. S., Altiparmak M. R., Batar B., Tun O., Yalin A. S., Tunckale A., Guven M., DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease. Molecular Biology Reports 2012 39 6995 7001 2-s2.0-84856387656 10.1007/s11033-012-1529-8
40. Cai Z., Chen H., Tao J., Guo W., Liu X., Zheng B., Sun W., Wang Y., Association of base excision repair gene polymorphisms with ESRD risk in a Chinese population. Oxidative Medicine and Cellular Longevity 2012 2012 928421 10.1155/2012/928421
41. Crawford A., Fassett R. G., Coombes J. S., Kunde D. A., Ahuja K. D. K., Robertson I. K., Ball M. J., Geraghty D. P., Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney disease. Nephrology Dialysis Transplantation 2011 26 9 2806 2813 2-s2.0-80052197723 10.1093/ndt/gfq828
42. Himmelfarb J., Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg? Seminars in Dialysis 2004 17 6 449 454 2-s2.0-12144267997 10.1111/j.0894-0959.2004.17605.x
43. Crawford A., Fassett R. G., Geraghty D. P., Kunde D. A., Ball M. J., Robertson I. K., Coombes J. S., Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. Gene 2012 501 89 103 2-s2.0-84860579889 10.1016/j.gene.2012.04.011
44. Lin Y.-S., Hung S.-C., Wei Y.-H., Tarng D.-C., GST M1 polymorphism associates with DNA oxidative damage and mortality among hemodialysis patients. Journal of the American Society of Nephrology 2009 20 2 405 415 2-s2.0-59949092089 10.1681/ASN.2008020227
45. Boaz M., Smetana S., Weinstein T., Matas Z., Gafter U., Iaina A., Knecht A., Weissgarten Y., Brunner D., Fainaru M., Green M. S., Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. The Lancet 2000 356 9237 1213 1218 2-s2.0-0034619027
46. Mann J. F. E., Lonn E. M., Yi Q., Gerstein H. C., Hoogwerf B. J., Pogue J., Bosch J., Dagenais G. R., Yusuf S., Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE Study. Kidney International 2004 65 4 1375 1380 2-s2.0-1642422335 10.1111/j.1523-1755.2004.00513.x
47. Tepel M., van der Giet M., Statz M., Jankowski J., Zidek W., The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation 2003 107 7 992 995 2-s2.0-0037465546 10.1161/01.CIR.0000050628.11305.30
48. Tarng D.-C., Liu T.-Y., Huang T.-P., Protective effect of vitamin C on 8-hydroxy-2′-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis patients. Kidney International 2004 66 2 820 831 2-s2.0-3242759885 10.1111/j.1523-1755.2004.00809.x
49. Kayabasi H., Yilmaz Z., Sit D., Kadiroglu A. K., Yilmaz E., The effects of Losartan on oxidative stress and inflammation in non-diabetic patients undergoing chronic hemodialysis. European Review For Medical and Pharmacological Sciences 2013 17 235 242
50. Delfino V. D. A., de Andrade Vianna A. C., Mocelin A. J., Barbosa D. S., Mise R. A., Matsuo T., Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients. Nutrition 2007 23 3 242 247 2-s2.0-33847617526 10.1016/j.nut.2007.01.002
51. Pergola P. E., Raskin P., Toto R. D., Meyer C. J., Huff J. W., Grossman E. B., Krauth M., Ruiz S., Audhya P., Christ-Schmidt H., Wittes J., Warnock D. G., Bardoxolone methyl and kidney function in CKD with type 2 diabetes. The New England Journal of Medicine 2011 365 4 327 336 2-s2.0-79960855656 10.1056/NEJMoa1105351
52. Oberg B. P., McMenamin E., Lucas F. L., McMonagle E., Morrow J., Ikizler T. A., Himmelfarb J., Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney International 2004 65 3 1009 1016 2-s2.0-1342322653 10.1111/j.1523-1755.2004.00465.x
53. Taki K., Tsuruta Y., Niwa T., Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients. The American Journal of Nephrology 2007 27 1 30 35 2-s2.0-33847668826 10.1159/000098542
54. Tumur Z., Shimizu H., Enomoto A., Miyazaki H., Niwa T., Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF- B activation. The American Journal of Nephrology 2010 31 5 435 441 2-s2.0-77950605070 10.1159/000299798
55. Friedman A. N., Bostom A. G., Selhub J., Levey A. S., Rosenberg I. H., The kidney and homocysteine metabolism. Journal of the American Society of Nephrology 2001 12 10 2181 2189 2-s2.0-0034836588
56. Massy Z. A., Ceballos I., Chadefaux-Vekemens B., Nguyen-Khoa T., Descamps-Latscha B., Drüeke T. B., Jungers P., Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients. Kidney International 2001 59 supplement 78 S243 S245 2-s2.0-0035122294
57. Ingrosso D., Cimmino A., Perna A. F., Masella L., De Santo N. G., De Bonis M. L., Vacca M., D' Esposito M., D'Urso M., Galletti P., Zappia V., Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. The Lancet 2003 361 9370 1693 1699 2-s2.0-0038663165 10.1016/S0140-6736(03)13372-7
58. Dodget J. E., Okano M., Dick F., Tsujimoto N., Chen T., Wang S., Ueda Y., Dyson N., Li E., Inactivation of Dnmt3b in mouse embryonic fibroblasts results in DNA hypomethylation, chromosomal instability, and spontaneous immortalization. Journal of Biological Chemistry 2005 280 18 17986 17991 2-s2.0-24044481947 10.1074/jbc.M413246200
59. Gugliucci A., Kotani K., Kimura S., Paraoxonase 1 in chronic kidney failure. Journal of Lipids 2012 2012 10 726048 10.1155/2012/726048
60. Tucker P. S., Dalbo V. J., Han T., Kingsley M. I., Clinical and research markers of oxidative stress in chronic kidney disease. Biomarkers 2013 18 103 115
61. Ward R. A., McLeish K. R., Oxidant stress in hemodialysis patients: what are the determining factors? Artificial Organs 2003 27 3 230 236 2-s2.0-0037357762 10.1046/j.1525-1594.2003.07170.x
62. Wu C.-C., Chen J.-S., Wu W.-M., Liao T.-N., Chu P., Lin S.-H., Chuang C.-H., Lin Y.-F., Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes. Nephrology Dialysis Transplantation 2005 20 1134 1139 2-s2.0-20844455941 10.1093/ndt/gfh764
63. Nguyen A. T., Lethias C., Zingraff J., Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. Kidney International 1985 28 2 158 167 2-s2.0-0021968947
64. Ward R. A., Ouseph R., McLeish K. R., Effects of high-flux hemodialysis on oxidant stress. Kidney International 2003 63 1 353 359 2-s2.0-0037213038 10.1046/j.1523-1755.2003.00741.x
65. Maggi E., Bellazzi R., Falaschi F., Frattoni A., Perani G., Finardi G., Gazo A., Nai M., Romanini D., Bellomo G., Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis? Kidney International 1994 45 3 876 883 2-s2.0-0028210390
66. Ramos L. F., Shintani A., Ikizler T. A., Himmelfarb J., Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. Journal of the American Society of Nephrology 2008 19 3 593 599 2-s2.0-40449129185 10.1681/ASN.2007030355
67. Chen J.-L., Huang Y.-J., Pan C.-H., Hu C.-W., Chao M.-R., Determination of urinary malondialdehyde by isotope dilution LC-MS/MS with automated solid-phase extraction: a cautionary note on derivatization optimization. Free Radical Biology and Medicine 2011 51 9 1823 1829 2-s2.0-80053593178 10.1016/j.freeradbiomed.2011.08.012
68. Paul J. L., Sall N.-D., Soni T., Poignet J.-L., Lindenbaum A., Man N.-K., Moatti N., Raichvarg D., Lipid peroxidation abnormalities in hemodialyzed patients. Nephron 1993 64 1 106 109 2-s2.0-0027534934
69. Esterbauer H., Schaur R. J., Zollner H., Chemistry and Biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine 1991 11 1 81 128 2-s2.0-0025814980 10.1016/0891-5849(91)90192-6
70. Miyata T., Kurokawa K., van Ypersele de Strihou C., Relevance of oxidative and carbonyl stress to long-term uremic complications. Kidney International 2000 58 76 supplement S120 S125 2-s2.0-0033865719
71. Aslam S., Santha T., Leone A., Wilcox C., Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis. Kidney International 2006 70 12 2109 2115 2-s2.0-33845302987 10.1038/sj.ki.5001983
72. Morrow J. D., Awad J. A., Boss H. J., Blair I. A., Roberts L. J. II, Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proceedings of the National Academy of Sciences of the United States of America 1992 89 22 10721 10725 2-s2.0-0026443725 10.1073/pnas.89.22. 10721
73. Morena M., Delbosc S., Dupuy A.-M., Canaud B., Cristol J.-P., Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodialysis International 2005 9 1 37 46 2-s2.0-21644431566 10.1111/j.1492-7535.2005.01116.x
74. Ramos R., Martínez-Castelao A., Lipoperoxidation and hemodialysis. Metabolism 2008 57 10 1369 1374 2-s2.0-51849150860 10.1016/j.metabol.2008.05. 004
75. Caimi G., Carollo C., Montana M., Iatrino R., Bondì B., Lo Presti R., Nitric oxide metabolites, leukocyte activation markers and oxidative status in dialyzed subjects. Blood Purification 2009 27 2 194 198 2-s2.0-58249098859 10.1159/000193218
76. Witko-Sarsat V., Friedlander M., Capeillère-Blandin C., Nguyen-Khoa T., Nguyen A. T., Zingraff J., Jungers P., Descamps-Latscha B., Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney International 1996 49 5 1304 1313 2-s2.0-0029948839
77. Modlinger P. S., Wilcox C. S., Aslam S., Nitric oxide, oxidative stress, and progression of chronic renal failure. Seminars in Nephrology 2004 24 4 354 365 2-s2.0-3142574854 10.1016/j.semnephrol.2004.04.007
78. Erdoǧan C., Unlüçerçi Y., Türkmen A., Kuru A., Cetin O., Bekpinar S., The evaluation of oxidative stress in patients with chronic renal failure. Clinica Chimica Acta 2002 322 157 161
79. Pischetsrieder M., Seidel W., Münch G., Schinzel R., N2-(1-carboxyethyl)deoxyguanosine, a nonenzymatic glycation adduct of DNA, induces single-strand breaks and increases mutation frequencies. Biochemical and Biophysical Research Communications 1999 264 2 544 549 2-s2.0-0033595749 10.1006/bbrc.1999.1528
80. Valko M., Izakovic M., Mazur M., Rhodes C. J., Telser J., Role of oxygen radicals in DNA damage and cancer incidence. Molecular and Cellular Biochemistry 2004 266 1-2 37 56 2-s2.0-9444258632 10.1023/B:MCBI.0000049134.69131.89
81. Kasai H., Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutation Research 1997 387 3 147 163 2-s2.0-0031469841 10.1016/S1383-5742(97)00035-5
82. Valko M., Rhodes C. J., Moncol J., Izakovic M., Mazur M., Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico-Biological Interactions 2006 160 1 1 40 2-s2.0-32444433202 10.1016/j.cbi.2005.12.009
83. Collins A., Comparison of different methods of measuring 8-oxoguanine as a marker of oxidative DNA damage. Free Radical Research 2000 32 4 333 341 2-s2.0-0034065401
84. Valavanidis A., Vlachogianni T., Fiotakis C., 8-hydroxy-2′- deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. Journal of Environmental Science and Health 2009 27 2 120 139 2-s2.0-66149088854
85. Orhan H., van Holland B., Krab B., Moeken J., Vermeulen N. P. E., Hollander P., Meerman J. H. N., Evaluation of a multi-parameter biomarker set for oxidative damage in man: increased urinary excretion of lipid, protein and DNA oxidation products after one hour of exercise. Free Radical Research 2004 38 12 1269 1279 2-s2.0-11044233670 10.1080/10715760400013763
86. Gedik C. M., Boyle S. P., Wood S. G., Vaughan N. J., Collins A. R., Oxidative stress in humans: validation of biomarkers of DNA damage. Carcinogenesis 2002 23 9 1441 1446 2-s2.0-0036713169
87. Kasai H., Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutation Research 1997 387 3 147 163 2-s2.0-0031469841 10.1016/S1383-5742(97)00035-5
88. Tarng D.-C., Huang T.-P., Wei Y.-H., Liu T.-Y., Chen H.-W., Wen Chen T., Yang W.-C., 8-Hydroxy-2′-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. The American Journal of Kidney Diseases 2000 36 5 934 944 2-s2.0-0033745670
89. Tarng D.-C., Chen T. W., Huang T.-P., Chen C.-L., Liu T.-Y., Wei Y.-H., Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients. Journal of the American Society of Nephrology 2002 13 5 1321 1330 2-s2.0-0036236428 10.1097/01.ASN.0000013301.11876.7E
90. Hu C.-W., Chao M.-R., Sie C.-H., Urinary analysis of 8-oxo-7,8- dihydroguanine and 8-oxo-7,8-dihydro-2′-deoxyguanosine by isotope-dilution LC-MS/MS with automated solid-phase extraction: study of 8-oxo-7,8- dihydroguanine stability. Free Radical Biology and Medicine 2010 48 1 89 97 2-s2.0-74149083811 10.1016/j.freeradbiomed.2009.10.029
91. Shigenaga M. K., Gimeno C. J., Ames B. N., Urinary 8-hydroxy-2′- deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proceedings of the National Academy of Sciences of the United States of America 1989 86 24 9697 9701 2-s2.0-0024815224 10.1073/pnas.86.24.9697
92. Cooke M. S., Olinski R., Loft S., Measurement and meaning of oxidatively modified DNA lesions in urine. Cancer Epidemiology Biomarkers and Prevention 2008 17 1 3 14 2-s2.0-38849090565 10.1158/1055-9965.EPI-07-0751
93. Hu C.-W., Huang Y.-J., Li Y.-J., Chao M.-R., Correlation between concentrations of 8-oxo-7,8-dihydro-2′-deoxyguanosine in urine, plasma and saliva measured by on-line solid-phase extraction LC-MS/MS. Clinica Chimica Acta 2010 411 17-18 1218 1222 2-s2.0-77954145429 10.1016/j.cca.2010.04.029
94. Schiffmann D., de Boni U., Dislocation of chromatin elements in prophase induced by diethylstilbestrol: a novel mechanism by which micronuclei can arise. Mutation Research 1991 246 1 113 122 2-s2.0-0026017544
95. Stopper H., Müller S. O., Micronuclei as a biological endpoint for genotoxicity: a minireview. Toxicology In Vitro 1997 11 5 661 667 2-s2.0-17444436990 10.1016/S0887-2333(97)00084-2
96. Cengiz K., Block A. M. W., Hossfeld D. K., Anthone R., Anthone S., Sandberg A. A., Sister chromatid exchange and chromosome abnormalities in uremic patients. Cancer Genetics and Cytogenetics 1988 36 1 55 67 2-s2.0-0024212214
97. Singh N. P., McCoy M. T., Tice R. R., Schneider E. L., A simple technique for quantitation of low levels of DNA damage in individual cells. Experimental Cell Research 1988 175 1 184 191 2-s2.0-0023919963
98. Kassie F., Parzefall W., Knasmüller S., Single cell gel electrophoresis assay: a new technique for human biomonitoring studies. Mutation Research 2000 463 1 13 31 2-s2.0-0034213140 10.1016/S1383-5742(00)00041-7
99. Stopper H., Schupp N., Klassen A., Sebekova K., Heidland A., Genomic damage in chronic renal failure: potential therapeutic interventions. Journal of Renal Nutrition 2005 15 1 81 86 2-s2.0-11844252556 10.1053/j.jrn.2004.09.017
100. Wei Y.-H., Mitochondrial DNA alterations as ageing-associated molecular events. Mutation Research 1992 275 3-6 145 155 2-s2.0-0026746336 10.1016/0921-8734(92)90019-L
101. Liu C.-S., Ko L.-Y., Lim P.-S., Kao S.-H., Wei Y.-H., Biomarkers of DNA damage in patients with end-stage renal disease: mitochondrial DNA mutation in hair follicles. Nephrology Dialysis Transplantation 2001 16 3 561 565 2-s2.0-0035090238
102. Stoyanova E., Sandoval S. B., Zúñiga L. A., El-Yamani N., Coll E., Pastor S., Reyes J., Andrés E., Ballarin J., Xamena N., Marcos R., Oxidative DNA damage in chronic renal failure patients. Nephrology Dialysis Transplantation 2010 25 3 879 885 2-s2.0-77649197464 10.1093/ndt/gfp575
103. Granata S., Zaza G., Simone S., Villani G., Latorre D., Pontrelli P., Carella M., Schena F. P., Grandaliano G., Pertosa G., Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease. BMC Genomics 2009 10, article 388 2-s2.0-69849083415 10.1186/1471-2164-10-388
104. Stopper H., Boullay F., Heidland A., Vienken J., Bahner U., Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients. The American Journal of Kidney Diseases 2001 38 296 301
105. Malachi T., Zevin D., Gafter U., Chagnac A., Slor H., Levi J., DNA repair and recovery of RNA synthesis in uremic patients. Kidney International 1993 44 2 385 389 2-s2.0-0027169341
106. Pinkus R., Weiner L. M., Daniel V., Role of oxidants and antioxidants in the induction of AP-1, NF- B, and glutathione S-transferase gene expression. Journal of Biological Chemistry 1996 271 23 13422 13429 2-s2.0-0029990552 10.1074/jbc.271.23.13422
107. Anilkumar N., Weber R., Zhang M., Brewer A., Shah A. M., Nox4 and Nox2 NADPH oxidases mediate distinct cellular redox signaling responses to agonist stimulation. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 7 1347 1354 2-s2.0-46249086250 10.1161/ATVBAHA.108.164277
108. Vayalil P. K., Iles K. E., Choi J., Yi A.-K., Postlethwait E. M., Liu R.-M., Glutathione suppresses TGF- β -induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter. The American Journal of Physiology 2007 293 5 L1281 L1292 2-s2.0-36349007768 10.1152/ajplung.00128.2007
109. Vayalil P. K., Olman M., Murphy-Ullrich J. E., Postlethwait E. M., Liu R.-M., Glutathione restores collagen degradation in TGF- β -treated fibroblasts by blocking plasminogen activator inhibitor-1 expression and activating plasminogen. The American Journal of Physiology 2005 289 6 L937 L945 2-s2.0-27944495712 10.1152/ajplung.00150.2005
110. Wu C.-C., Chen J.-S., Lin S.-H., Chu P., Lin Y.-F., Lin S.-M., Liao T.-N., Aberrant activation of the TNF- α system and production of fas and scavenger receptors on monocytes in patients with end-stage renal disease. Artificial Organs 2005 29 9 701 707 2-s2.0-27744550473 10.1111/j.1525-1594.2005. 29110.x
111. Galli F., Ghibelli L., Buoncristiani U., Bordoni V., D'Intini V., Benedetti S., Canestrari F., Ronco C., Floridi A., Mononuclear leukocyte apoptosis in haemodialysis patients: the role of cell thiols and vitamin E. Nephrology Dialysis Transplantation 2003 18 8 1592 1600 2-s2.0-0041663616 10.1093/ndt/gfg210
112. Wu C.-C., Liao T.-N., Lu K.-C., Chen J.-S., Chu P., Lin S.-H., Chuang C.-H., Lin Y.-F., Apoptotic markers on lymphocytes and monocytes are unchanged during single hemodialysis sessions using either regenerated cellulose or polysulfone membranes. Clinical Nephrology 2005 64 3 198 204 2-s2.0-24644517559
113. London G. M., Drueke T. B., Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney International 1997 51 6 1678 1695 2-s2.0-0030967042
114. Aviram M., Rosenblat M., Etzioni A., Levy R., Activation of NADPH oxidase is required for macrophage-mediated oxidation of low-density lipoprotein. Metabolism 1996 45 9 1069 1079 2-s2.0-0029783343 10.1016/S0026-0495(96)90005-0
115. Xia Y., Tsai A.-L., Berka V., Zweier J. L., Superoxide generation from endothelial nitric-oxide synthase: a Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. Journal of Biological Chemistry 1998 273 40 25804 25808 2-s2.0-0032475865 10.1074/jbc.273.40.25804
116. Cooke J. P., Dzau V. J., Nitric oxide synthase: role in the genesis of vascular disease. Annual Review of Medicine 1997 48 489 509 2-s2.0-0031054463 10.1146/annurev.med.48.1.489
117. Miyata T., Oda O., Inagi R., Iida Y., Araki N., Yamada N., Horiuchi S., Taniguchi N., Maeda K., Kinoshita T., β 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. Journal of Clinical Investigation 1993 92 3 1243 1252 2-s2.0-0027161984
118. Capeillere-Blandin C., Delaveau T., Descamps-Latscha B., Structural modifications of human β 2 microglobulin treated with oxygen-derived radicals. Biochemical Journal 1991 277 1 175 182 2-s2.0-0025784163
119. Šebeková K., Wagner Z., Schupp N., Boor P., Genomic damage and malignancy in end-stage renal failure: do advanced glycation end products contribute? Kidney and Blood Pressure Research 2007 30 1 56 66 2-s2.0-33847073276 10.1159/000099029
120. Loft S., Poulsen H. E., Cancer risk and oxidative DNA damage in man. Journal of Molecular Medicine 1996 74 297 312 2-s2.0-0031024465
121. Stopper H., Schupp N., Bahner U., Sebekova K., Klassen A., Heidland A., Genomic damage in end-stage renal failure: potential involvement of advanced glycation end products and carbonyl stress. Seminars in Nephrology 2004 24 5 474 478 2-s2.0-5444227771 10.1016/j.semnephrol.2004.06.025
122. Himmelfarb J., Hakim R. M., Oxidative stress in uremia. Current Opinion in Nephrology and Hypertension 2003 12 593 598
123. Devaraj S., Jialal I., The effects of alpha-tocopherol on critical cells in atherogenesis. Current Opinion in Lipidology 1998 9 1 11 15 2-s2.0-0031972958 10.1097/00041433-199802000-00004
124. Diaz M. N., Frei B., Vita J. A., Keaney J. F. Jr., Antioxidants and atherosclerotic heart disease. The New England Journal of Medicine 1997 337 6 408 416 2-s2.0-0030839661 10.1056/NEJM199708073370607
125. Brunet J., Boily M.-J., Cordeau S., Des Rosiers C., Effects of N-acetylcysteine in the rat heart reperfused after low-flow ischemia: evidence for a direct scavenging of hydroxyl radicals and a nitric oxide-dependent increase in coronary flow. Free Radical Biology and Medicine 1995 19 5 627 638 2-s2.0-0029151282 10.1016/0891-5849(95)00077-B
126. DiMari J., Megyesi J., Udvarhelyi N., Price P., Davis R., Safirstein R., N-acetyl cysteine ameliorates ischemic renal failure. The American Journal of Physiology 1997 272 3 F292 F298 2-s2.0-0030764921
127. Andrews N. P., Prasad A., Quyyumi A. A., N-acetylcysteine improves coronary and peripheral vascular function. Journal of the American College of Cardiology 2001 37 1 117 123 2-s2.0-0035171760 10.1016/S0735-1097(00)01093-7
128. Hsu S.-P., Chiang C.-K., Yang S.-Y., Chien C.-T., N-acetylcysteine for the management of anemia and oxidative stress in hemodialysis patients. Nephron 2010 116 3 c207 c216 2-s2.0-77954184657 10.1159/000317201
129. Libetta C., Sepe V., Esposito P., Galli F., Dal Canton A., Oxidative stress and inflammation: implications in uremia and hemodialysis. Clinical
130. Nickenig G., Harrison D. G., The AT1-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis. Circulation 2002 105 3 393 396 2-s2.0-0037154324 10.1161/hc0302.102618
131. Pueyo M. E., Gonzalez W., Nicoletti A., Savoie F., Arnal J.-F., Michel J.-B., Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor- B activation induced by intracellular oxidative stress. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 3 645 651 2-s2.0-0034060298
132. Imaeda A., Tanigawa T., Aoki T., Kondo Y., Nakamura N., Yoshikawa T., Antioxidative effects of fluvastatin and its metabolites against oxidative DNA damage in mammalian cultured cells. Free Radical Research 2001 35 6 789 801 2-s2.0-0035692711
133. Wautier M.-P., Chappey O., Corda S., Stern D. M., Schmidt A. M., Wautier J.-L., Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. The American Journal of Physiology 2001 280 5 E685 E694 2-s2.0-0034996659
134. Bierhaus A., Hofmann M. A., Ziegler R., Nawroth P. P., AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovascular Research 1998 37 3 586 600 2-s2.0-0032029363 10.1016/S0008-6363(97)00233-2
135. Krivosíková Z., Dusinská M., Spustová V., Sebeková K., Blazícek P., Heidland A., Dzúrik R., DNA damage of lymphocytes in experimental chronic renal failure: beneficial effects of losartan. Kidney International 2001 78 supplement S212 S215
136. Moberly J. B., Logan J., Borum P. R., Story K. O., Webb L. E., Jassal S. V., Mupas L., Rodela H., Alghamdi G. A., Moran J. E., Wolfson M., Martis L., Oreopoulos D. G., Elevation of whole-blood glutathione in peritoneal dialysis patients by L-2-oxothiazolidine-4-carboxylate, a cysteine prodrug (procysteine). Journal of the American Society of Nephrology 1998 9 6 1093 1099 2-s2.0-0031749131
137. Stopper H., Treutlein A.-T., Bahner U., Schupp N., Schmid U., Brink A., Perna A., Heidland A., Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation. Nephrology Dialysis Transplantation 2008 23 10 3272 3279 2-s2.0-52449133701 10.1093/ndt/gfn254
138. Heinz J., Kropf S., Luley C., Dierkes J., Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis. The American Journal of Kidney Diseases 2009 54 3 478 489 2-s2.0-68849101346 10.1053/j.ajkd.2009.01.266
139. Wang X., Fenech M., A comparison of folic acid and 5- methyltetrahydrofolate for prevention of DNA damage and cell death in human lymphocytes in vitro. Mutagenesis 2003 18 1 81 86 2-s2.0-0037238069 10.1093/mutage/18.1.81
140. Fenech M., Baghurst P., Luderer W., Turner J., Record S., Ceppi M., Bonassi S., Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, β -carotene and high intake of pantothenic acid, biotin and riboflavin are significantly associated with increased genome instability: results from a dietary intake and micronucleus index survey in South Australia. Carcinogenesis 2005 26 5 991 999 2-s2.0-19844378446 10.1093/carcin/bgi042
141. MacGregor J. T., Wehr C. M., Hiatt R. A., Peters B., Tucker J. D., Langlois R. G., Jacob R. A., Jensen R. H., Yager J. W., Shigenaga M. K., Frei B., Eynon B. P., Ames B. N., 'Spontaneous' genetic damage in man: evaluation of interindividual variability, relationship among markers of damage, and influence of nutritional status. Mutation Research 1997 377 1 125 135 2-s2.0-0030942667 10.1016/S0027-5107(97)00070-5
142. Titenko-Holland N., Jacob R. A., Shang N., Balaraman A., Smith M. T., Micronuclei in lymphocytes and exfoliated buccal cells of postmenopausal women with dietary changes in folate. Mutation Research 1998 417 2-3 101 114 2-s2.0-0031662942 10.1016/S1383-5718(98)00104-1
143. Ruiz S., Pergola P. E., Zager R. A., Vaziri N. D., Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney International 2013 83 1029 1041
144. Dinkova-Kostova A. T., Liby K. T., Stephenson K. K., Holtzclaw W. D., Gao X., Suh N., Williams C., Risingsong R., Honda T., Gribble G. W., Sporn M. B., Talalay P., Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. Proceedings of the National Academy of Sciences of the United States of America 2005 102 12 4584 4589 2-s2.0-20144383831 10.1073/pnas.0500815102
145. Yates M. S., Tauchi M., Katsuoka F., Flanders K. C., Liby K. T., Honda T., Gribble G. W., Johnson D. A., Johnson J. A., Burton N. C., Guilarte T. R., Yamamoto M., Sporn M. B., Kensler T. W., Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. Molecular Cancer Therapeutics 2007 6 1 154 162 2-s2.0-33846786713 10.1158/1535-7163.MCT-06-0516
146. Sporn M. B., Liby K. T., Yore M. M., Fu L., Lopchuk J. M., Gribble G. W., New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress. Journal of Natural Products 2011 74 3 537 545 2-s2.0-79953242026 10.1021/np100826q
147. Levonen A.-L., Landar A., Ramachandran A., Ceaser E. K., Dickinson D. A., Zanoni G., Morrow J. D., Darley-Usmar V. M., Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochemical Journal 2004 378 2 373 382 2-s2.0-1642282736 10.1042/BJ20031049
148. Ahmad R., Raina D., Meyer C., Kharbanda S., Kufe D., Triterpenoid CDDO-Me blocks the NF- B pathway by direct inhibition of IKK β on Cys-179. Journal of Biological Chemistry 2006 281 47 35764 35769 2-s2.0-33845976705 10.1074/jbc.M607160200
149. Floridi A., Antolini F., Galli F., Fagugli R. M., Floridi E., Buoncristiani U., Daily haemodialysis improves indices of protein glycation. Nephrology Dialysis Transplantation 2002 17 5 871 878 2-s2.0-0036092127